Stockscreener 앱 받기
12.30
2.58%
-0.32
전일 마감가:
$12.62
열려 있는:
$12.3
하루 거래량:
719.71K
Relative Volume:
0.61
시가총액:
$937.27M
수익:
$54.55M
순이익/손실:
$-193.57M
주가수익비율:
-4.2561
EPS:
-2.89
순현금흐름:
$-181.86M
1주 성능:
+3.32%
1개월 성능:
+31.08%
6개월 성능:
+9.09%
1년 성능:
-50.90%
1일 변동 폭
$12.17
$12.53
1주일 범위
$11.37
$13.23
52주 변동 폭
$8.18
$29.56
누릭스 테라퓨틱스 Stock (NRIX) Company Profile
명칭
Nurix Therapeutics Inc
전화
(415) 660-5320
주소
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
NRIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
12.26 | 1.28B | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.04 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.25 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.36 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.91 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
누릭스 테라퓨틱스 Stock (NRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-03-17 | 개시 | Leerink Partners | Market Perform |
| 2024-12-10 | 개시 | BTIG Research | Buy |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | Jefferies | Buy |
| 2024-09-06 | 재개 | Robert W. Baird | Outperform |
| 2024-07-31 | 개시 | Truist | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-09 | 개시 | Barclays | Overweight |
| 2023-02-28 | 개시 | Oppenheimer | Outperform |
| 2022-10-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-12-29 | 개시 | H.C. Wainwright | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-04-30 | 재개 | Piper Sandler | Overweight |
| 2021-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2020-11-19 | 개시 | Robert W. Baird | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
| 2020-08-18 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | Stifel | Buy |
모두보기
누릭스 테라퓨틱스 주식(NRIX)의 최신 뉴스
Needham Reiterates Buy Rating for NRIX, Maintains Price Target | - GuruFocus
What to expect from Nurix Therapeutics Inc. in the next 30 daysJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
13 Analysts Have This To Say About Nurix Therapeutics - Benzinga
How sustainable is Nurix Therapeutics Inc. stock dividend payoutJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
BTIG Reiterates Buy Rating for Nurix Therapeutics (NRIX) with $2 - GuruFocus
Signal strength of Nurix Therapeutics Inc. stock in tech scannersVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com
Is Nurix Therapeutics Inc. stock ready for breakoutJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com
How moving averages guide Nurix Therapeutics Inc. trading2025 Price Action Summary & Intraday High Probability Setup Alerts - newser.com
Analyzing Nurix Therapeutics Inc. with risk reward ratio charts2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Can Nurix Therapeutics Inc. stock hit record highs againWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - newser.com
Why Nurix Therapeutics Inc. stock is a must watch in 2025July 2025 Action & Weekly Top Stock Performers List - newser.com
Applying chart zones and confluence areas to Nurix Therapeutics Inc.Weekly Gains Summary & Real-Time Volume Spike Alerts - newser.com
Insider Sell: Houte Van Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus
Nurix therapeutics CFO van Houte sells $78,931 in stock By Investing.com - Investing.com Canada
Full technical analysis of Nurix Therapeutics Inc. stockDividend Hike & Stepwise Swing Trade Plans - newser.com
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting - The Manila Times
Nurix (NASDAQ: NRIX) to present NX-5948 data in CLL and Waldenström at ASH - Stock Titan
Key metrics from Nurix Therapeutics Inc.’s quarterly dataWeekly Stock Recap & Detailed Earnings Play Alerts - newser.com
Is Nurix Therapeutics Inc. stock a buy for dividend growthBuy Signal & Momentum Based Trading Ideas - newser.com
Nurix Therapeutics Inc. stock daily chart insightsJuly 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
Can Nurix Therapeutics Inc. recover in the next quarterExit Point & Fast Exit and Entry Trade Guides - newser.com
Will Nurix Therapeutics Inc. stock deliver consistent dividendsWeekly Trend Report & Daily Technical Forecast Reports - newser.com
Visual trend scoring systems applied to Nurix Therapeutics Inc.Weekly Profit Summary & AI Powered Trade Plan Recommendations - newser.com
Why Nurix Therapeutics Inc. stock is seen as undervalued2025 Biggest Moves & Short-Term Trading Opportunity Alerts - newser.com
How institutional ownership impacts Nurix Therapeutics Inc. stockOptions Play & High Accuracy Swing Trade Signals - newser.com
Is Nurix Therapeutics Inc. building a consolidation baseAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
What technical charts say about Nurix Therapeutics Inc. stockJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com
Will Nurix Therapeutics Inc. stock go up soonJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 3,130 Shares - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells $52,313.60 in Stock - MarketBeat
Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies - MSN
누릭스 테라퓨틱스 (NRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):